Automodification of N‐terminal serine residues facilitates PARP2 release from DNA
The FEBS Journal · 2026-06 · 293 (11) · 3274-3287
DOI: 10.1111/febs.70409 ↗At a glance
Journal article in The FEBS Journal, published online on 2026-01-24. Written by Saurabh Singh Dhakar and 6 co-authors. Institution: Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland. Major MEDLINE topics: Poly(ADP-ribose) Polymerases, Serine, DNA. Cited 1 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: Boehringer Ingelheim Fonds, Magnus Ehrnroothin Säätiö, Terveyden Tutkimuksen Toimikunta.
Abstract (original language)
ADP‐ribosyltransferases PARP1 and PARP2 are involved in DNA repair mechanisms and play a major role in detecting DNA damage. PARP1/2 enzymes transfer the ADP‐ribosyl moiety from NAD + to DNA damage response proteins, histones and to itself, activating the DNA repair cascade. Recent studies have shown that histone PARylation factor 1 (HPF1) forms a joint active site with the catalytic domain of PARP1/2 and alters their target modification site from glutamate/aspartate to serine. In this work, we identified key serine residues within the N‐terminus of full‐length human PARP2 that are the main targets of automodification. We demonstrated this using site‐directed mutagenesis, gel‐based PARylation assays of automodification reactions, and by measuring the release of PARP2 from the DNA damage site using a fluorescence polarization assay. We show that, in the presence of HPF1, PARP2 serine 8 and serine 73 are predominantly ADP‐ribosylated and serine 8, which is present in the two human PARP2 isoforms, is the major site for PARP2 automodification. Our results provide insight into the mechanistic role of the N‐terminus of PARP2 in the PARylation‐dependent release of PARP2 from DNA damage sites.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Faculty of Biochemistry and Molecular Medicine, University of Oulu, Finland.
- Faculty of Medicine, Department of Physiological Chemistry, Biomedical Center (BMC), LMU Munich, Martinsried, Germany.
- International Max Planck Research School (IMPRS) for Molecules of Life, Martinsried, Germany.
- Biocenter Oulu, University of Oulu, Finland.
ORCID profiles: Lari Lehtiö
Funding
- Boehringer Ingelheim Fonds
- Magnus Ehrnroothin Säätiö
- Terveyden Tutkimuksen Toimikunta
- Deutsche Forschungsgemeinschaft
Cite
APA
Dhakar, S. S., Galera-Prat, A., Cai, J., Preisser, J., Kiema, T. R., Ladurner, A., & Lehtiö, L. (2026). Automodification of N‐terminal serine residues facilitates PARP2 release from DNA. The FEBS Journal, 293(11), 3274-3287. https://doi.org/10.1111/febs.70409
Vancouver
Dhakar SS, Galera-Prat A, Cai J, Preisser J, Kiema TR, Ladurner A, et al. Automodification of N‐terminal serine residues facilitates PARP2 release from DNA. The FEBS Journal. 2026;293(11):3274-3287. doi:10.1111/febs.70409
BibTeX
@article{Dhakar2026,
author = {Dhakar, Saurabh Singh and Galera-Prat, Albert and Cai, Jin and Preisser, Julia and Kiema, Tiila-Riikka and Ladurner, Andreas and Lehtiö, Lari},
title = {Automodification of N‐terminal serine residues facilitates PARP2 release from DNA},
journal = {The FEBS Journal},
year = {2026},
volume = {293},
number = {11},
pages = {3274--3287},
doi = {10.1111/febs.70409}
}
EUVIMED